The issues associated with the number of CAR-T patients needing ICU care are not just limited to the ICU but instead are a challenge to be tackled on an institutional level. Michael Darmon, MD, PhD, of Saint-Louis University Hospital, Paris, France, discusses how earlier ICU admission is often associated with early ICU discharge and so could help to prevent blockages. This interview took place at the CAR-T Cell Therapy and the ICU meeting in London, UK, which was organized by EuroCARTForce.